Lipella Pharmaceuticals Statistics

Total Valuation

LIPO has a market cap or net worth of $2.95 million. The enterprise value is $993,842.

Market Cap	2.95M
Enterprise Value	993,842

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

LIPO has 1.21 million shares outstanding. The number of shares has increased by 41.54% in one year.

Current Share Class	1.21M
Shares Outstanding	1.21M
Shares Change (YoY)	+41.54%
Shares Change (QoQ)	+17.72%
Owned by Insiders (%)	29.37%
Owned by Institutions (%)	9.69%
Float	853,802

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.06
Forward PS	n/a
PB Ratio	1.63
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.02.

Current Ratio	3.47
Quick Ratio	3.01
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -198.12% and return on invested capital (ROIC) is -121.01%.

Return on Equity (ROE)	-198.12%
Return on Assets (ROA)	-101.59%
Return on Invested Capital (ROIC)	-121.01%
Return on Capital Employed (ROCE)	-264.69%
Revenue Per Employee	$76,622
Profits Per Employee	-$716,609
Employee Count	7
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.03% in the last 52 weeks. The beta is 0.26, so LIPO's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-55.03%
50-Day Moving Average	2.87
200-Day Moving Average	3.37
Relative Strength Index (RSI)	48.74
Average Volume (20 Days)	46,394

Short Selling Information

The latest short interest is 55,751, so 4.61% of the outstanding shares have been sold short.

Short Interest	55,751
Short Previous Month	58,196
Short % of Shares Out	4.61%
Short % of Float	6.53%
Short Ratio (days to cover)	0.01

Income Statement

In the last 12 months, LIPO had revenue of $536,357 and -$5.02 million in losses. Loss per share was -$4.79.

Revenue	536,357
Gross Profit	536,357
Operating Income	-5.08M
Pretax Income	-4.74M
Net Income	-5.02M
EBITDA	-5.08M
EBIT	-5.08M
Loss Per Share	-$4.79

Full Income Statement

Balance Sheet

The company has $2.18 million in cash and $47,605 in debt, giving a net cash position of $2.14 million or $1.77 per share.

Cash & Cash Equivalents	2.18M
Total Debt	47,605
Net Cash	2.14M
Net Cash Per Share	$1.77
Equity (Book Value)	1.92M
Book Value Per Share	1.59
Working Capital	1.86M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.95M
Capital Expenditures	n/a
Free Cash Flow	-3.69M
FCF Per Share	-$3.05

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-947.23%
Pretax Margin	-935.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LIPO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.54%
Shareholder Yield	n/a
Earnings Yield	-160.21%
FCF Yield	-117.79%

Analyst Forecast

The average price target for LIPO is $16.00, which is 555.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	555.74%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 8, 2024. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Nov 8, 2024
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2